Nicola Normanno joins “From Policy to Practice” – EAPM
European Alliance for Personalised Medicine (EAPM) shared a post on LinkedIn:
“Speaker Announcement | Nicola Normanno joins “From Policy to Practice”
We’re honoured to welcome Nicola Normanno as a featured speaker at our upcoming side event during the European Society of Pathology (ESP) Congress in Vienna!
September 6th, 2025
Austria Center Vienna (ACV)
13:00 – 15:30 CET
Register here to attend the event.
Dr. Normanno, Scientific Director at IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori” – IRST Srl and President of IQN Path ASBL, is internationally recognized for his groundbreaking work in molecular diagnostics, liquid biopsy, and precision oncology.
As a leader in biomarker discovery and NGS implementation, Dr. Normanno has helped define the clinical and technical standards that underpin high-quality cancer diagnostics across Europe.
At the event, he will be “Setting the Scene” for our policy-focused opening session — helping frame why current HER2 testing models must evolve to meet the demands of modern oncology and how international collaboration can drive lasting change.
Don’t miss the insights of one of the foremost experts in molecular pathology!”
More posts featuring Nicola Normanno on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023